This year’s global deceleration of the venture capital market is broad, impacting most startup ecosystems, sectors and stages. In the first quarter of 2022, CB Insights’ dataset indicates that some $10.4 billion was invested into global health tech startups. That figure is off 36% from Q4 2021.